GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Pre-Tax Income

Roche Holding AG (Roche Holding AG) Pre-Tax Income : $15,861 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Roche Holding AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Roche Holding AG's pretax income for the six months ended in Dec. 2023 was $5,672 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $15,861 Mil. Roche Holding AG's pretax margin was 16.45%.

During the past 13 years, Roche Holding AG's highest Pretax Margin was 30.80%. The lowest was 22.98%. And the median was 25.31%.


Roche Holding AG Pre-Tax Income Historical Data

The historical data trend for Roche Holding AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Pre-Tax Income Chart

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,908.20 20,221.75 18,890.34 17,525.76 16,280.07

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,155.27 11,322.41 5,734.22 10,188.81 5,671.83

Competitive Comparison of Roche Holding AG's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Roche Holding AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Pre-Tax Income falls into.



Roche Holding AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Roche Holding AG's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=17801.804+0+-1152.868+225.486+-594.357
=16,280

Roche Holding AG's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=6511.332+0+-587.419+149.167+-401.248
=5,672

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $15,861 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG  (OTCPK:RHHBY) Pre-Tax Income Explanation

Roche Holding AG's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=5671.832/34487.743
=16.45%

During the past 13 years, Roche Holding AG's highest Pretax Margin was 30.80%. The lowest was 22.98%. And the median was 25.31%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (Roche Holding AG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.